In this TUMS TECH series, Dr. Mohammad Hossein Yazdi, Associate Professor of Pharmaceutical Biotechnology and Head of the Biotechnology Research Center at Tehran University of Medical Sciences, presents the activities and achievements of the center. The Biotechnology Research Center at Tehran University of Medical Sciences conducts applied research focused on nanobiotechnology, phage therapy, immunotherapy, and cancer, and converts the results into therapeutic and industrial products. Its major achievements include a bacteriophage collection, therapeutic nanoparticles, and industrial enzymes. The center is also involved in clinical trials in collaboration with hospitals and pharmaceutical companies, and is ranked among the top five biotechnology centers in Iran.

The latest episode of TUMS Tech unveiled OncoPore, a groundbreaking device for cancer surgery. Developed through a joint collaboration between distinguished experts from the University of Tehran and Tehran University of Medical Sciences, this innovative device represents a new era in complex surgeries for cancer patients.OncoPore is an advanced device that plays a vital role in complex cancer surgeries. It empowers surgeons to target cancer cells with greater precision, accelerating patient recovery. This scientific innovation, symbolizing collaboration and technological advancement in Iran, paves the way for more advanced treatments and increased hope for cancer patients.